NCT03244488View on ClinicalTrials.gov

Mental Ability Challenge Study in Adults With and Without HIV

CompletedOBSERVATIONAL
Enrollment

22

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
HIV-1-infectionAging, PrematureCognitive ImpairmentMemory ImpairmentHIV-Associated Cognitive Motor Complex
Interventions
DRUG

Scopolamine Injectable Product

2.5 or 5 mcg/kg of scopolamine via IV

DRUG

Mecamylamine Pill

10 or 20mg of mecamylamine orally

Trial Locations (1)

37212

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT03244488 - Mental Ability Challenge Study in Adults With and Without HIV | Biotech Hunter | Biotech Hunter